Publications

Editorial: Type III interferons: Emerging roles beyond antiviral barrier defense

Frontiers in Immunology

Read

Editorial: Type III interferons: Emerging roles beyond antiviral barrier defense

Frontiers in Immunology

Read

Type III and Not Type I Interferons Efficiently Prevent the Spread of Rotavirus in Human Intestinal Epithelial Cells.

J Virol

Read

USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING.

Cell Death Dis.

Read

A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection

Comm Biol

Read

Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries

Nat. Genetic

Read

A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells

Cell metabolism

Read

The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters

mBio

Read

The link between menin and pleiotrophin in the tumor biology of pancreatic neuroendocrine neoplasms

Cancer Science

Read

Conserved Induction of Distinct Antiviral Signalling Kinetics by Primate Interferon Lambda 4 Proteins

Frontiers Immunology

Read